These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 195039)
1. Inhibition of canine adrenergic transmission by an analog of dopamine: GJH-166. Sharabi FM; Long JP; Cannon JG J Pharmacol Exp Ther; 1977 Jul; 202(1):97-104. PubMed ID: 195039 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the sympathetic nervous system by a series of heterocyclic congeners of dopamine. Sharabi FM; Long JP; Cannon JG; Hatheway GJ J Pharmacol Exp Ther; 1976 Dec; 199(3):630-8. PubMed ID: 994020 [TBL] [Abstract][Full Text] [Related]
3. Peripheral vascular actions of alpha-methyldopa in the dog. Rodrigues-Pereira E Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):105-15. PubMed ID: 201221 [TBL] [Abstract][Full Text] [Related]
4. Influence of apomorphine on sympathetic neural transmission in the nictitating membrane of the cat. György L; Dóda M Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):194-204. PubMed ID: 195545 [TBL] [Abstract][Full Text] [Related]
5. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog. Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandins as modulators of the autonomic nervous system. Brody MJ; Kadowitz PJ Fed Proc; 1974 Jan; 33(1):48-60. PubMed ID: 4359038 [No Abstract] [Full Text] [Related]
7. Adrenergic re-innervation of smooth muscle of nictitating membrane by preganglionic sympathetic fibres. Ceccarelli B; Clementi F; Mantegazza P J Physiol; 1972 Jan; 220(1):211-27. PubMed ID: 4333827 [TBL] [Abstract][Full Text] [Related]
9. Influence of angiotensin I, angiontensin II and cocaine on adrenergic vasoconstrictor responses in the dog hindpaw. Kadowitz PJ; Sweet CS; Brody MJ J Pharmacol Exp Ther; 1972 Nov; 183(2):275-83. PubMed ID: 4343414 [No Abstract] [Full Text] [Related]
10. Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine. Long JP; Heintz S; Cannon JG; Kim J J Pharmacol Exp Ther; 1975 Feb; 192(2):336-42. PubMed ID: 1117421 [TBL] [Abstract][Full Text] [Related]
11. [Isolated smooth muscle of the cat nictitating membrane with intact sympathetic nerve supply]. Häusler G; Haefely W Helv Physiol Pharmacol Acta; 1968; 26(3):CR337-9. PubMed ID: 5719355 [No Abstract] [Full Text] [Related]
12. Adrenergic reinnervation of sommoth muscle of nictitating membrane by preganglionic sympathetic fibers. Ceccarelli B; Clementi F; Mantegazza P Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:293-. PubMed ID: 5052480 [No Abstract] [Full Text] [Related]
13. Differential effects of prostaglandins E 1 , E 2 , F 1 and F 2 on adrenergic vasoconstriction in the dog hindpaw. Kadowitz PJ; Sweet CS; Brody MJ J Pharmacol Exp Ther; 1971 Jun; 177(3):641-9. PubMed ID: 4328021 [No Abstract] [Full Text] [Related]
14. [Tyramine tachyphylaxis; its recovery and interaction with enzyme inhibitors in arterial pressure and cat nictitating membrane]. Lorenzo Fernandez P; Moreno A; Mediavilla A; Navas J Arch Inst Farmacol Exp (Madr); 1969; 21(1):11-42. PubMed ID: 4328437 [No Abstract] [Full Text] [Related]
15. Ganglionic and adrenergic effects of 2-phenylquinoline methiodide analogues. Hitner H; Di Gregorio GJ; DiPalma JR; Gennaro A Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):264-71. PubMed ID: 4360339 [No Abstract] [Full Text] [Related]
16. The effect of propranolol on vascular responses to sympathetic nerve stimulation. Dawes PM; Faulkner DC Br J Pharmacol; 1975 Apr; 53(4):517-24. PubMed ID: 238703 [TBL] [Abstract][Full Text] [Related]
17. Purinergic inhibition of adrenergic transmission in rabbit blood vessels. Su C J Pharmacol Exp Ther; 1978 Feb; 204(2):351-61. PubMed ID: 202694 [TBL] [Abstract][Full Text] [Related]
18. On the adrenergic neuron blocking activity of 1-methyl-3-keto-4-phenylquinuclidinium bromide (MA540) during acute and chronic administration. Hong E Arzneimittelforschung; 1976; 26(9):1657-62. PubMed ID: 1036694 [TBL] [Abstract][Full Text] [Related]